- Home
- QXO vs ELAN Comparison
QXO vs ELAN Comparison
Compare QXO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QXO
- ELAN
- Stock Information
- Founded
- QXO 1988
- ELAN 1954
- Country
- QXO United States
- ELAN United States
- Employees
- QXO N/A
- ELAN N/A
- Industry
- QXO EDP Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- QXO Technology
- ELAN Health Care
- Exchange
- QXO Nasdaq
- ELAN Nasdaq
- Market Cap
- QXO 5.7B
- ELAN 6.6B
- IPO Year
- QXO N/A
- ELAN 2018
- Fundamental
- Price
- QXO $22.01
- ELAN $14.80
- Analyst Decision
- QXO Strong Buy
- ELAN Buy
- Analyst Count
- QXO 5
- ELAN 7
- Target Price
- QXO $33.25
- ELAN $15.33
- AVG Volume (30 Days)
- QXO 13.4M
- ELAN 4.9M
- Earning Date
- QXO 08-13-2025
- ELAN 08-07-2025
- Dividend Yield
- QXO 119.06%
- ELAN N/A
- EPS Growth
- QXO N/A
- ELAN N/A
- EPS
- QXO N/A
- ELAN 0.75
- Revenue
- QXO $55,945,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- QXO $8,691.52
- ELAN $4.28
- Revenue Next Year
- QXO $139.58
- ELAN $4.67
- P/E Ratio
- QXO N/A
- ELAN $19.80
- Revenue Growth
- QXO 0.21
- ELAN 1.42
- 52 Week Low
- QXO $10.61
- ELAN $8.02
- 52 Week High
- QXO $157.28
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- QXO 59.48
- ELAN 69.55
- Support Level
- QXO $21.31
- ELAN $14.47
- Resistance Level
- QXO $22.03
- ELAN $14.81
- Average True Range (ATR)
- QXO 1.03
- ELAN 0.36
- MACD
- QXO -0.24
- ELAN 0.01
- Stochastic Oscillator
- QXO 30.19
- ELAN 93.41
About QXO QXO Inc. Common Stock
QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution, and service sectors. It provides consulting and professional services, specialized programming, training, and technical support. It also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence, and other applications.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.